Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 60%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is a leading provider of infusion and home healthcare management solutions, with a focus on post-acute care services. Despite facing headwinds in Q1/26 due to changes in insurance plans, the company's diversified service offerings and strong momentum in its acute therapy business indicate potential for growth. With its exposure to Stelara significantly reduced and expansion of its advanced practitioner capabilities, Option Care Health is well-positioned for long-term margin expansion and potential multiple expansion. These factors make Option Care Health a strong candidate for long-term outperformance in the healthcare industry.

Bears say

Option Care Health is facing a number of challenges, including slowing revenue growth and elevated SG&A costs that are impacting its earnings. These challenges are expected to continue in the short-term, and the company's guidance for the rest of 2026 is below analyst expectations, indicating a potential struggle to meet its financial targets. While the company has opportunities to improve its margins and become more efficient, there are also risks such as slowing specialty growth and increased competition that could impact its future performance.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 60% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $79.90, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $79.90, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.